| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3373 |
| Trial ID | NCT05776407 |
| Disease | Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ThisCAR-T19A |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Chongqing University Cancer Hospital |
| Other ID(s) | FT400-006-2 |
| Cohort 1 | |||||||||||
|
|||||||||||